# E4A Systemic Mastocytosis/Emerging Indication HEOR Strategy Specialist at Sanofi

Sanofi is hiring an E4A Systemic Mastocytosis/Emerging Indication HEOR Strategy Specialist in Cambridge, United States. It pays $149k-$215k a year and Level rates it Little AI ●○○○; you can [apply on Level](https://jobsbylevel.com/go/48b381d5-8175-48ce-abd4-55bccbc7e240).

AI Level 1, AI centrality 34 out of 100. Cambridge, MA.

## Details

- Company: [Sanofi](https://jobsbylevel.com/companies/sanofi)
- AI level: AI Level 1 (score 34 out of 100)
- Location: Cambridge, MA
- Salary: $149k-$215k
- Posted: October 10, 2026
- Apply: https://jobsbylevel.com/go/48b381d5-8175-48ce-abd4-55bccbc7e240

## Description

Job title: E4A Systemic Mastocytosis/Emerging Indication HEOR Strategy Specialist Location: Cambridge, MA About the Job HEVA's mission is to conduct, communicate, and translate evidence to demonstrate the value of Sanofi's products and support optimal access and treatment outcomes for patients. HEVA Vision, Mission, and Values We are one bold HEOR team leveraging innovative HEOR to transform patient care and access. As HEOR experts, we lead the generation and dissemination of robust, business-relevant evidence to demonstrate value and drive access to medicines. The HEVA organization is driven by five core values that define how we work and deliver impact. We operate as One Team, partnering without boundaries while pursuing a Bold Purpose through ambitious, measurable goals. Grounded in Scientific Excellence with Relevance and deep technical expertise, we embrace Innovation in Action to transform how we research and deliver Impact for People, creating meaningful outcomes for patients, the healthcare ecosystem, and our colleagues who make it all possible. Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. About Sanofi We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Main Responsibilities This role will lead US‑focused Health Economic and Outcomes Research activities for AYVAKIT® in Systemic Mastocytosis and emerging pipeline assets within the US Rare/Oncology HEVA team, providing US insights and executional leadership while remaining aligned to — but not accountable for — global HEVA strategy. Lead the design and execution of US-focused HEOR for AYVAKIT® (avapritinib) in Systemic Mastocytosis and assigned emerging assets — including economic modelling, database analysis, observational research, RWE studies, systematic literature review, evidence synthesis, and AMCP dossier development — setting US evidence generation priorities and incorporating them into broader Sanofi planning documents such as the Integrated Evidence Generation Plan (IEGP); operate with medium independence for strategic work and high independence for tactical execution, consistent with L3-2 expectations. Translate HEVA evidence into US business and policy impact by driving payer engagement, value positioning, and access strategies for AYVAKIT® in the US marketplace; understand and address US payer evidence requirements across managed care, specialty pharmacy, and rare disease payer dynamics; and support the development of compliant and impactful US evidence dissemination pathways (e.g., HCEI, PIE, CFL) including payer dossiers, field materials, and publications. Operate as part of a multi-functional US brand team responsible for designing research programs to meet the evidentiary standards of US reimbursement authorities and third-party payers; provide recommendations to ensure clinical and real-world evidence programs support US payer differentiation and value demonstration; and contribute to cross-functional US planning processes including brand planning, lifecycle management, and launch readiness for AYVAKIT® and pipeline assets. Serve as the US HEVA representative within the broader global HEVA team, ensuring the US perspective is well represented in global IEGPs, clinical development programs, and market access strategies; translate global evidence packages into US-specific value narratives and payer-facing materials; and engage with ICER review processes and the US policy landscape as relevant to Systemic Mastocytosis and emerging assets.

The description is cut here. Read the full offer: https://jobsbylevel.com/jobs/e4a-systemic-mastocytosis-emerging-indication-heor-strategy-specialist-at-sanofi-c3a552

Source: https://jobsbylevel.com/jobs/e4a-systemic-mastocytosis-emerging-indication-heor-strategy-specialist-at-sanofi-c3a552

## Cite this page

Level. https://jobsbylevel.com/jobs/e4a-systemic-mastocytosis-emerging-indication-heor-strategy-specialist-at-sanofi-c3a552.

Get job alerts: https://jobsbylevel.com/newsletter